- Home
- BNRG vs SILO Comparison
BNRG vs SILO Comparison
Compare BNRG & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNRG
- SILO
- Stock Information
- Founded
- BNRG 2012
- SILO 2010
- Country
- BNRG Israel
- SILO United States
- Employees
- BNRG N/A
- SILO N/A
- Industry
- BNRG
- SILO Apparel
- Sector
- BNRG
- SILO Consumer Discretionary
- Exchange
- BNRG Nasdaq
- SILO Nasdaq
- Market Cap
- BNRG 10.0M
- SILO 8.8M
- IPO Year
- BNRG 2022
- SILO N/A
- Fundamental
- Price
- BNRG $1.31
- SILO $1.08
- Analyst Decision
- BNRG
- SILO
- Analyst Count
- BNRG 0
- SILO 0
- Target Price
- BNRG N/A
- SILO N/A
- AVG Volume (30 Days)
- BNRG 57.2K
- SILO 139.6K
- Earning Date
- BNRG 03-04-2025
- SILO 05-12-2025
- Dividend Yield
- BNRG N/A
- SILO N/A
- EPS Growth
- BNRG N/A
- SILO N/A
- EPS
- BNRG N/A
- SILO N/A
- Revenue
- BNRG N/A
- SILO $72,102.00
- Revenue This Year
- BNRG N/A
- SILO $1.86
- Revenue Next Year
- BNRG N/A
- SILO N/A
- P/E Ratio
- BNRG N/A
- SILO N/A
- Revenue Growth
- BNRG N/A
- SILO N/A
- 52 Week Low
- BNRG $0.60
- SILO $0.77
- 52 Week High
- BNRG $3.27
- SILO $4.50
- Technical
- Relative Strength Index (RSI)
- BNRG 48.84
- SILO 28.08
- Support Level
- BNRG $1.19
- SILO $1.20
- Resistance Level
- BNRG $1.30
- SILO $1.39
- Average True Range (ATR)
- BNRG 0.09
- SILO 0.09
- MACD
- BNRG 0.00
- SILO -0.02
- Stochastic Oscillator
- BNRG 41.38
- SILO 0.00
About BNRG Brenmiller Energy Ltd
Brenmiller Energy Ltd is a technology company that develops, produces, markets, and sells thermal energy storage. The technology of the company allows electrification and decarbonization of the industrial industry sector for integration with renewable energy sources and further reduction of carbon emissions.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.